Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Gregory

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|June 25, 1990
Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cellsC K Leonard, M W Spellman, L Riddle, et al.
The American Review of Respiratory Disease|July 1, 1985
High-frequency ventilation attenuation of hypoxic pulmonary vasoconstriction. The role of prostacyclinR C Wetzel, J B Gordon, T J Gregory, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1991
Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinityA Ashkenazi, D H Smith, S A Marsters, et al.
Journal of Virology|October 1, 1989
Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4R A Byrn, I Sekigawa, S M Chamow, et al.
The American Journal of Clinical Nutrition|February 1, 1996
Rapid modulation of lung and liver macrophage phospholipid fatty acids in endotoxemic rats by continuous enteral feeding with n-3 and gamma-linolenic fatty acidsJ D Palombo, S J DeMichele, E E Lydon, et al.
Clinical and Diagnostic Laboratory Immunology|July 1, 1996
Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation GroupG J Gorse, G B Patel, F K Newman, et al.
Cellular Immunology|November 1, 1987
The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitroM R Shalaby, J F Krowka, T J Gregory, et al.
Critical Care Medicine|March 1, 1997
Effects of eicosapentaenoic and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic ratsP Mancuso, J Whelan, S J DeMichele, et al.
Virology|December 22, 1999
Development of bivalent (B/E) vaccines able to neutralize CCR5-dependent viruses from the United States and ThailandP W Berman, W Huang, L Riddle, et al.
AIDS (London, England)|May 1, 1994
Comparison of the immune response to recombinant gp120 in humans and chimpanzeesP W Berman, D J Eastman, D M Wilkes, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|June 25, 1990
Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cellsC K Leonard, M W Spellman, L Riddle, et al.
The American Review of Respiratory Disease|July 1, 1985
High-frequency ventilation attenuation of hypoxic pulmonary vasoconstriction. The role of prostacyclinR C Wetzel, J B Gordon, T J Gregory, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1991
Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinityA Ashkenazi, D H Smith, S A Marsters, et al.
Journal of Virology|October 1, 1989
Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4R A Byrn, I Sekigawa, S M Chamow, et al.
The American Journal of Clinical Nutrition|February 1, 1996
Rapid modulation of lung and liver macrophage phospholipid fatty acids in endotoxemic rats by continuous enteral feeding with n-3 and gamma-linolenic fatty acidsJ D Palombo, S J DeMichele, E E Lydon, et al.
Clinical and Diagnostic Laboratory Immunology|July 1, 1996
Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation GroupG J Gorse, G B Patel, F K Newman, et al.
Cellular Immunology|November 1, 1987
The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitroM R Shalaby, J F Krowka, T J Gregory, et al.
Critical Care Medicine|March 1, 1997
Effects of eicosapentaenoic and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic ratsP Mancuso, J Whelan, S J DeMichele, et al.
Virology|December 22, 1999
Development of bivalent (B/E) vaccines able to neutralize CCR5-dependent viruses from the United States and ThailandP W Berman, W Huang, L Riddle, et al.
AIDS (London, England)|May 1, 1994
Comparison of the immune response to recombinant gp120 in humans and chimpanzeesP W Berman, D J Eastman, D M Wilkes, et al.
Pageof 3